Appendix CEvidence Tables

Publication Details

Acronyms

ACS

American Cancer Society

AHRQ

Agency for Healthcare Research and Quality

AOR

adjusted odds ratio

BRFSS

Behavioral Risk Factor Surveillance Survey

CAD

computer-aided detection

CAHPS

Consumer Assessment of Healthcare Providers and Systems

CCME

Carolina Center for Medical Excellence

CDC

Centers for Disease Control and Prevention

CHIS

California Health Interview Survey

CI

confidence interval

CONSORT

Consolidated Standards of Reporting Trials

CORI

Clinical Outcomes Research Initiative

CPT

current procedural terminology

CRC

colorectal cancer

CT

computed tomography

CTC

computed tomographic colonography

CTS

Community Tracking Study

DCBE

double contrast barium enema

DERS

Direct Endoscopic Referral System

DNA

deoxyribonucleic acid

DRE

digital rectal examination

FAP

familial adenomatous polyposis

FIT

fecal immunochemical test

FSS

fee-for-service

FFS + SUPP

fee-for-service Medicare + supplemental insurance

FIT

fecal immunochemical test

FOBT

fecal occult blood test

FS

flexible sigmoidoscopy

gFOBT

guaiac-based fecal occult blood test

G

group

GI

gastrointestinal

GI

gastroenterologist

HEDIS

Healthcare Effectiveness Data and Information Set

HINTS

Health Information National Trends Survey

HMO

health maintenance organization

HNPCC

hereditary nonpolylposis colorectal cancer

ICD

International Classification of Diseases

iFOBT

immunochemical fecal occult blood test

KQ

key question

LHA

lay health advisors

MCA

managed care activity

MCBS

Medicare Current Beneficiary Survey

MEPS

Medical Expenditure Panel Survey

MeSH

Medical Subject Heading

MMC

Medicare managed care

MMSA

metropolitan or micropolitan statistical areas

MR

magnetic resonance

MRI

magnetic resonance imaging

MSTF

Multi-Society Task Force

MSTF

Multi-Society Task Force

NCI

National Cancer Institute

NCQA

National Committee on Quality Assurance

NHIS

National Health Interview Survey

NIH

National Institutes of Health

N

number

NR

not reported

OMAR

Office of Medical Applications of Research

OR

odds ratio

PCP

primary care physician

PET

positron emission tomography

PHE

periodic health examination

PSA

prostate-specific antigen

PSAs

public service announcements

RCTs

randomized controlled trials

RDD

random digital dialing

RR

relative risk

RTC

Randomized Control Trial

RTI-UNC EPC

RTI International–University of North Carolina Evidence-based Practice Center

SES

socioeconomic status

SI

standard intervention

STROBE

STrengthening the Reporting of OBservational studies in Epidemiology

TEP

Technical Expert Panel

TFCPS

Task Force on Community Preventive Services

TI

tailored intervention

TIP

tailored intervention plus reminder phone call

US

United States

USPSTF

US Preventive Services Task Force

VA

Veterans Administration

Evidence Table 1. KQ 2: What factors influence the use of colorectal cancer screening

Evidence Table 2. KQ 3: Which strategies are effective in increasing the appropriate use of colorectal cancer screening and surveillance?

Evidence Table 3. KQ 4: Current and projected capacity to deliver colorectal cancer screening and surveillance

Evidence Table 4. KQ5: Effective approaches for monitoring use and quality of colorectal cancer screening

References

1.
Afable-Munsuz A, Liang SY, Ponce NA, et al. Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med. 2009 Aug;24(8):963–70. [PMC free article: PMC2710471] [PubMed: 19472016]
2.
Ananthakrishnan AN, Schellhase KG, Sparapani RA, et al. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007 Feb 12;167(3):258–64. [PubMed: 17296881]
3.
Ata A, Elzey JD, Insaf TZ, et al. Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations. Cancer Detect Prev. 2006;30(2):134–43. [PubMed: 16638628]
4.
Atlas SJ, Grant RW, Ferris TG, et al. Patient-physician connectedness and quality of primary care. Ann Intern Med. 2009 Mar 3;150(5):325–35. [PMC free article: PMC2975389] [PubMed: 19258560]
5.
Berkowitz Z, Hawkins NA, Peipins LA, et al. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults. J Am Geriatr Soc. 2008 Feb;56(2):307–14. [PubMed: 18070002]
6.
Cardarelli R, Thomas JE. Having a personal health care provider and receipt of colorectal cancer testing. Ann Fam Med. 2009 Jan‐Feb;7(1):5–10. [PMC free article: PMC2625828] [PubMed: 19139443]
7.
Cairns CP, Viswanath K. Communication and colorectal cancer screening among the uninsured: data from the Health Information National Trends Survey (United States) Cancer Causes Control. 2006 Nov;17(9):1115–25. [PubMed: 17006717]
8.
Carcaise-Edinboro P, Bradley CJ. Influence of patient-provider communication on colorectal cancer screening. Med Care. 2008 Jul;46(7):738–45. [PubMed: 18580394]
9.
Carlos RC, Fendrick AM, Ellis J, et al. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening? J Am Coll Radiol. 2004 Oct;1(10):769–76. [PubMed: 17411698]
10.
Carlos RC, Fendrick AM, Patterson SK, et al. Associations in breast and colon cancer screening behavior in women. Acad Radiol. 2005 Apr;12(4):451–8. [PubMed: 15831418]
11.
Christman LK, Abdulla R, Jacobsen PB, et al. Colorectal cancer screening among a sample of community health center attendees. J Health Care Poor Underserved. 2004 May;15(2):281–93. [PubMed: 15253379]
12.
Coughlin SS, Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005 Oct;6(4):369–78. [PubMed: 16210678]
13.
Diaz JA, Roberts MB, Goldman RE, et al. Effect of language on colorectal cancer screening among Latinos and non-Latinos. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2169–73. [PMC free article: PMC2568081] [PubMed: 18708410]
14.
Etzioni DA, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004 Dec 1;101(11):2523–32. [PubMed: 15505783]
15.
Fenton JJ, Cai Y, Weiss NS, et al. Delivery of cancer screening: how important is the preventive health examination? Arch Intern Med. 2007 Mar 26;167(6):580–5. [PMC free article: PMC3443471] [PubMed: 17389289]
16.
Ferrante JM, Ohman-Strickland P, Hudson SV, et al. Colorectal cancer screening among obese versus non-obese patients in primary care practices. Cancer Detect Prev. 2006;30(5):459–65. [PMC free article: PMC1761119] [PubMed: 17067753]
17.
Fisher DA, Jeffreys A, Coffman CJ, et al. Barriers to full colon evaluation for a positive fecal occult blood test. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1232–5. [PubMed: 16775188]
18.
Fox SA, Heritage J, Stockdale SE, et al. Cancer screening adherence: does physician-patient communication matter? Patient Educ Couns. 2009 May;75(2):178–84. [PubMed: 19250793]
19.
Garman KS, Jeffreys A, Coffman C, et al. Colorectal cancer screening, comorbidity, and follow-up in elderly patients. Am J Med Sci. 2006 Oct;332(4):159–63. [PubMed: 17031239]
20.
Gilbert A, Kanarek N. Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev Med. 2005 Aug;41(2):367–79. [PubMed: 15917034]
21.
Goel MS, Wee CC, McCarthy EP, et al. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003 Dec;18(12):1028–35. [PMC free article: PMC1494963] [PubMed: 14687262]
22.
Gupta S, Tong L, Allison JE, et al. Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy. Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2373–9. [PMC free article: PMC2767330] [PubMed: 19745221]
23.
Heo M, Allison DB, Fontaine KR. Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health. 2004 Nov 8;4:53. [PMC free article: PMC529449] [PubMed: 15533259]
24.
Honda K, Kagawa-Singer M. Cognitive mediators linking social support networks to colorectal cancer screening adherence. J Behav Med. 2006 Oct;29(5):449–60. [PubMed: 16958004]
25.
Hudson SV, Ohman-Strickland P, Cunningham R, et al. The effects of teamwork and system support on colorectal cancer screening in primary care practices. Cancer Detect Prev. 2007;31(5):417–23. [PMC free article: PMC2244946] [PubMed: 18031947]
26.
Janz NK, Wren PA, Schottenfeld D, et al. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med. 2003 Dec;37(6 Pt 1):627–34. [PubMed: 14636796]
27.
Jerant AF, Arellanes RE, Franks P. Factors associated with Hispanic/non-Hispanic white colorectal cancer screening disparities. J Gen Intern Med. 2008 Aug;23(8):1241–5. [PMC free article: PMC2517962] [PubMed: 18500503]
28.
Jerant AF, Fenton JJ, Franks P. Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med. 2008 Jun 23;168(12):1317–24. [PubMed: 18574089]
29.
Katz ML, James AS, Pignone MP, et al. Colorectal cancer screening among African American church members: a qualitative and quantitative study of patient-provider communication. BMC Public Health. 2004 Dec 15;4:62. [PMC free article: PMC544572] [PubMed: 15601463]
30.
Klabunde CN, Vernon SW, Nadel MR, et al. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care. 2005 Sep;43(9):939–44. [PubMed: 16116360]
31.
Koroukian SM, Litaker D, Dor A, et al. Use of preventive services by Medicare fee-for‐service beneficiaries: does spillover from managed care matter? Med Care. 2005 May;43(5):445–52. [PubMed: 15838408]
32.
Koroukian SM, Xu F, Dor A, et al. Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status. Health Serv Res. 2006 Dec;41(6):2136–54. [PMC free article: PMC1955310] [PubMed: 17116113]
33.
Lemon S, Zapka J, Puleo E, et al. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Public Health. 2001 Aug;91(8):1264–72. [PMC free article: PMC1446758] [PubMed: 11499116]
34.
Levy BT, Dawson J, Hartz AJ, et al. Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med. 2006 Sep;31(3):193–201. [PubMed: 16905029]
35.
Ling BS, Klein WM, Dang Q. Relationship of communication and information measures to colorectal cancer screening utilization: results from HINTS. J Health Commun. 2006;11( Suppl 1):181–90. [PubMed: 16641083]
36.
Matthews BA, Nattinger AB, Venkatesan T, et al. Colorectal cancer screening among midwestern community-based residents: indicators of success. J Community Health. 2007 Apr;32(2):103–20. [PubMed: 17571524]
37.
McQueen A, Vernon SW, Meissner HI, et al. Are there gender differences in colorectal cancer test use prevalence and correlates? Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):782–91. [PubMed: 16614124]
38.
Messina CR, Lane DS, Colson RC. Colorectal cancer screening among users of county health centers and users of private physician practices. Public Health Rep. 2009 Jul–Aug;124(4):568–78. [PMC free article: PMC2693171] [PubMed: 19618794]
39.
Muus KJ, Baker-Demaray T, McDonald LR, et al. Body mass index and cancer screening in older American Indian and Alaska Native men. J Rural Health. 2009 Winter;25(1):104–8. [PubMed: 19166569]
40.
Nguyen BH, McPhee SJ, Stewart SL, et al. Colorectal cancer screening in Vietnamese Americans. J Cancer Educ. 2008 Jan‐Mar;23(1):37–45. [PMC free article: PMC2505345] [PubMed: 18444045]
41.
O'Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med. 2002 Feb;17(2):144–54. [PMC free article: PMC1495005] [PubMed: 11841530]
42.
O'Malley AS, Forrest CB, Feng S, et al. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005 Oct 10;165(18):2129–35. [PubMed: 16217003]
43.
Peterson NB, Murff HJ, Ness RM, et al. Colorectal cancer screening among men and women in the United States. J Womens Health (Larchmt) 2007 Jan–Feb;16(1):57–65. [PubMed: 17324097]
44.
Pham HH, Schrag D, Hargraves JL, et al. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005 Jul 27;294(4):473–81. [PubMed: 16046654]
45.
Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004 Apr;19(4):332–8. [PMC free article: PMC1492191] [PubMed: 15061742]
46.
Schenck AP, Klabunde CN, Davis WW. Racial differences in colorectal cancer test use by Medicare consumers. Am J Prev Med. 2006 Apr;30(4):320–6. [PubMed: 16530619]
47.
Schneider EC, Rosenthal M, Gatsonis CG, et al. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Med Care. 2008 Sep;46(9 Suppl 1):S84–90. [PubMed: 18725838]
48.
Schootman M, Jeffe DB, Baker EA, et al. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006 Mar;60(3):202–7. [PMC free article: PMC2465556] [PubMed: 16476748]
49.
Schumacher MC, Slattery ML, Lanier AP, et al. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control. 2008 Sep;19(7):725–37. [PMC free article: PMC2574651] [PubMed: 18307048]
50.
Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004 May 15;100(10):2093–103. [PubMed: 15139050]
51.
Shah M, Zhu K, Potter J. Hispanic acculturation and utilization of colorectal cancer screening in the United States. Cancer Detect Prev. 2006;30(3):306–12. [PubMed: 16872756]
52.
Shapiro JA, Seeff LC, Thompson TD, et al. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623–30. [PubMed: 18628413]
53.
Shih YC, Zhao L, Elting LS. Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood) 2006 Jul–Aug;25(4):1153–62. [PubMed: 16835198]
54.
Shih YC, Elting LS, Levin B. Disparities in colorectal screening between US-born and foreign-born populations: evidence from the 2000 National Health Interview Survey. J Cancer Educ. 2008 Jan–Mar;23(1):18–25. [PubMed: 18444042]
55.
Sun WY, Basch CE, Wolf RL, et al. Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med. 2004 Aug;39(2):323–9. [PubMed: 15226041]
56.
Thompson B, Coronado G, Chen L, et al. Celebremos la salud! a community randomized trial of cancer prevention (United States) Cancer Causes Control. 2006 Jun;17(5):733–46. [PubMed: 16633921]
57.
Thompson B, Coronado G, Neuhouser M, et al. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer. 2005 Jun 15;103(12):2491–8. [PubMed: 15880744]
58.
Thompson B, Coronado GD, Solomon CC, et al. Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes Control. 2002 Oct;13(8):719–28. [PubMed: 12420950]
59.
Thorpe LE, Mostashari F, Hajat A, et al. Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey. Cancer. 2005 Sep 1;104(5):1075–82. [PubMed: 16044401]
60.
Trivers KF, Shaw KM, Sabatino SA, et al. Trends in colorectal cancer screening disparities in people aged 50–64 years, 2000–2005. Am J Prev Med. 2008 Sep;35(3):185–93. [PubMed: 18617355]
61.
Walsh JM, Kaplan CP, Nguyen B, et al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med. 2004 Feb;19(2):156–66. [PMC free article: PMC1492137] [PubMed: 15009795]
62.
Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005 Jul;41(1):23–9. [PubMed: 15916989]
63.
Wong ST, Gildengorin G, Nguyen T, et al. Disparities in colorectal cancer screening rates among Asian Americans and non‐ Latino whites. Cancer. 2005 Dec 15;104(12 Suppl):2940–7. [PMC free article: PMC1810896] [PubMed: 16276538]
64.
Yano EM, Soban LM, Parkerton PH, et al. Primary care practice organization influences colorectal cancer screening performance. Health Serv Res. 2007 Jun;42(3 Pt 1):1130–49. [PMC free article: PMC1955248] [PubMed: 17489907]
65.
Yip MP, Tu SP, Chun A, et al. Participation in colorectal cancer screening among Chinese Americans. Asian Pac J Cancer Prev. 2006 Oct–Dec;7(4):645–50. [PubMed: 17250445]
66.
Young WF, McGloin J, Zittleman L, et al. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2007;(3):238–45. [PubMed: 17565524]
67.
Zapka JG, Puleo E, Vickers-Lahti M, et al. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002 Jul;23(1):28–35. [PubMed: 12093420]
68.
Ayanian JZ, Sequist TD, Zaslavsky AM, et al. Physician reminders to promote surveillance colonoscopy for colorectal adenomas: a randomized controlled trial. J Gen Intern Med. 2008 Jun;23(6):762–7. [PMC free article: PMC2517870] [PubMed: 18386103]
69.
Braun KL, Fong M, Kaanoi ME, et al. Testing a culturally appropriate, theory-based intervention to improve colorectal cancer screening among Native Hawaiians. Prev Med. 2005 Jun;40(6):619–27. [PMC free article: PMC2914227] [PubMed: 15850857]
70.
Campbell MK, James A, Hudson MA, et al. Improving multiple behaviors for colorectal cancer prevention among african american church members. Health Psychol. 2004 Sep;23(5):492–502. [PubMed: 15367069]
71.
Church TR, Yeazel MW, Jones RM, et al. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. J Natl Cancer Inst. 2004 May 19;96(10):770–80. [PubMed: 15150305]
72.
Costanza ME, Luckmann R, Stoddard AM, et al. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect Prev. 2007;31(3):191–8. [PubMed: 17646058]
73.
Denberg TD, Coombes JM, Byers TE, et al. Effect of a mailed brochure on appointment-keeping for screening colonoscopy: a randomized trial. Ann Intern Med. 2006 Dec 19;145(12):895–900. [PubMed: 17179058]
74.
Dietrich AJ, Tobin JN, Cassells A, et al. Telephone care management to improve cancer screening among low-income women: a randomized, controlled trial. Ann Intern Med. 2006 Apr 18;144(8):563–71. [PMC free article: PMC3841972] [PubMed: 16618953]
75.
Dietrich AJ, Tobin JN, Cassells A, et al. Translation of an efficacious cancer-screening intervention to women enrolled in a Medicaid managed care organization. Ann Fam Med. 2007 Jul–Aug;5(4):320–7. [PMC free article: PMC1934974] [PubMed: 17664498]
76.
Dolan JG, Frisina S. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002 Mar–Apr;22(2):125–39. [PubMed: 11958495]
77.
Jandorf L, Gutierrez Y, Lopez J, et al. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005 Jun;82(2):216–24. [PMC free article: PMC3456577] [PubMed: 15888638]
78.
Ling BS, Schoen RE, Trauth JM, et al. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med. 2009 Jan 12;169(1):47–55. [PubMed: 19139323]
79.
Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007 Nov 1;110(9):2083–91. [PubMed: 17893869]
80.
Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening. A randomized, controlled trial. Ann Intern Med. 2000 Nov 21;133(10):761–9. [PubMed: 11085838]
81.
Potter MB, Phengrasamy L, Hudes ES, et al. Offering annual fecal occult blood tests at annual flu shot clinics increases colorectal cancer screening rates. Ann Fam Med. 2009 Jan–Feb;7(1):17–23. [PMC free article: PMC2625837] [PubMed: 19139445]
82.
Roetzheim RG, Christman LK, Jacobsen PB, et al. A randomized controlled trial to increase cancer screening among attendees of community health centers. Ann Fam Med. 2004 Jul–Aug;2(4):294–300. [PMC free article: PMC1466693] [PubMed: 15335126]
83.
Ruffin MTt, Fetters MD, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev Med. 2007 Oct;45(4):267–73. [PubMed: 17689600]
84.
Sequist TD, Zaslavsky AM, Marshall R, et al. Patient and physician reminders to promote colorectal cancer screening: a randomized controlled trial. Arch Intern Med. 2009 Feb 23;169(4):364–71. [PMC free article: PMC2683730] [PubMed: 19237720]
85.
Stokamer CL, Tenner CT, Chaudhuri J, et al. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med. 2005 Mar;20(3):278–82. [PMC free article: PMC1490069] [PubMed: 15836533]
86.
Tu SP, Taylor V, Yasui Y, et al. Promoting culturally appropriate colorectal cancer screening through a health educator: a randomized controlled trial. Cancer. 2006 Sep 1;107(5):959–66. [PubMed: 16865681]
87.
Zapka JG, Lemon SC, Puleo E, et al. Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination. Ann Intern Med. 2004 Nov 2;141(9):683–92. [PubMed: 15520425]
88.
Ballew C, Lloyd BG, Miller SH. Capacity for colorectal cancer screening by colonoscopy, Montana, 2008. Am J Prev Med. 2009 Apr;36(4):329–32. [PubMed: 19285198]
89.
Benuzillo JG, Jacobs ET, Hoffman RM, et al. Rural-urban differences in colorectal cancer screening capacity in Arizona. J Community Health. 2009 Sep 2 [PubMed: 19728054]
90.
Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med. 2003 Aug 1;115(2):129–33. [PubMed: 12893399]
91.
Butterly L, Olenec C, Goodrich M, et al. Colonoscopy demand and capacity in New Hampshire. Am J Prev Med. 2007 Jan;32(1):25–31. [PubMed: 17184962]
92.
Hoffman RM, Stone SN, Herman C, et al. New Mexico's capacity for increasing the prevalence of colorectal cancer screening with screening colonoscopies. Prev Chronic Dis. 2005 Jan;2(1):A07. [PMC free article: PMC1323310] [PubMed: 15670460]
93.
Hur C, Gazelle GS, Zalis ME, et al. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology. 2004 Nov;127(5):1312–21. [PubMed: 15521000]
94.
Ladabaum U, Song K. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Gastroenterology. 2005 Oct;129(4):1151–62. [PubMed: 16230069]
95.
Pickhardt PJ, Hassan C, Laghi A, et al. Is there sufficient MDCT capacity to provide colorectal cancer screening with CT colonography for the U.S. population? AJR Am J Roentgenol. 2008 Apr;190(4):1044–9. [PubMed: 18356453]
96.
Robertson RH, Burkhardt JH, Powell MP, et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999–2001. Prev Med. 2006 Jun;42(6):460–2. [PubMed: 16563479]
97.
Seeff LC, Manninen DL, Dong FB, et al. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology. 2004 Dec;127(6):1661–9. [PubMed: 15578502]
98.
Seeff LC, Richards TB, Shapiro JA, et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology. 2004 Dec;127(6):1670–7. [PubMed: 15578503]
99.
Vijan S, Inadomi J, Hayward RA, et al. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther. 2004 Sep 1;20(5):507–15. [PubMed: 15339322]
100.
El-Serag HB, Petersen L, Hampel H, et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006 Nov 13;166(20):2202–8. [PubMed: 17101937]
101.
Fiscella K, Holt K, Meldrum S, et al. Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res. 2006;6:122. [PMC free article: PMC1592485] [PubMed: 17010195]
102.
Hall HI, Van Den Eeden SK, Tolsma DD, et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med. 2004 Jul;39(1):27–35. [PubMed: 15207983]
103.
Haque R, Chiu V, Mehta KR, et al. An automated data algorithm to distinguish screening and diagnostic colorectal cancer endoscopy exams. J Natl Cancer Inst Monogr. 2005(35):116–8. [PubMed: 16287897]
104.
Pignone M, Scott TL, Schild LA, et al. Yield of claims data and surveys for determining colon cancer screening among health plan members. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):726–31. [PubMed: 19273480]
105.
Schenck AP, Klabunde CN, Warren JL, et al. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among Medicare enrollees in fee for service. Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):799–804. [PubMed: 18381471]
106.
Schenck AP, Klabunde CN, Warren JL, et al. Data sources for measuring colorectal endoscopy use among Medicare enrollees. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2118–27. [PubMed: 17932360]
107.
Schneider EC, Nadel MR, Zaslavsky AM, et al. Assessment of the scientific soundness of clinical performance measures: a field test of the National Committee for Quality Assurance's colorectal cancer screening measure. Arch Intern Med. 2008 Apr 28;168(8):876–82. [PubMed: 18443264]